pre-ipo
Stage
About
Ascelia Pharma AB is a biotechnology company developing and commercializing orphan oncology drugs, with clinical-stage candidates Orviglance® and Oncoral targeting rare cancer conditions.
Explore Ascelia Pharma AB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.